StockNews.com Begins Coverage on Cara Therapeutics (NASDAQ:CARA)
Equities researchers at StockNews.com assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Cara Therapeutics Trading Up 10.7 % Shares of Cara Therapeutics stock opened at $5.70 on Friday. Cara Therapeutics has a 12-month […]
Equities researchers at StockNews.com assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Cara Therapeutics Trading Up 10.7 % Shares of Cara Therapeutics stock opened at $5.70 on Friday. Cara Therapeutics has a 12-month […]
